Early dual treatment helps late-diagnosed PAH patients catch up

Jul 21, 2025

1 min read

Early use of dual therapy helps newly-diagnosed pulmonary arterial hypertension patients do as well as patients six months past diagnosis.

Newly-diagnosed patients' health is often worse than patients who have been treated for six months or more. However, US registry data showed that newly-diagnosed patients given macitentan and tadalafil had, after a year, similar survival and hospitalization rates to prevalent patients. Starting dual therapy soon after diagnosis may have some benefit.

Read the Advances in Therapy article

Recent Posts

More than half of pulmonary fibrosis patients have PH

There is not much data looking at pulmonary hypertension (PH) in interstitial lung disease, except in idiopathic pulmonary fibrosis (IPF). A study of patients with pulmonary fibrosis found that 60.7%

Frequent imaging of children with PH may lead to high radiation doses

A 41-study review of children with non-cancer chronic diseases looked at how much radiation they were exposed to during their relatively frequent medical imaging. Children with PH were included. The r

What affects physical activity for people with PH?

A UK study examined the factors that affected physical activity participation among people with pulmonary hypertension (PH). They found four themes: fear of breathlessness; lack of motivation and a de

Comments